🎉 M&A multiples are live!
Check it out!

GSK India Valuation Multiples

Discover revenue and EBITDA valuation multiples for GSK India and other public comps.

See GSK India Valuation Multiples

GSK India Overview

About GSK India

GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives majority of its revenue from India.


Founded

1924

HQ

India
Employees

3.2K+

Website

gsk-india.com

Financials

LTM Revenue $421M

LTM EBITDA $124M

EV

$4.1B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

GSK India Financials

GSK India has a last 12-month revenue of $421M and a last 12-month EBITDA of $124M.

In the most recent fiscal year, GSK India achieved revenue of $397M and an EBITDA of $102M.

GSK India expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See GSK India valuation multiples based on analyst estimates

GSK India P&L

FY 2022 FY 2023 FY 2024 LTM NTM
Revenue $377M $372M $397M $421M XXX
Gross Profit $209M $216M $233M XXX XXX
Gross Margin 56% 58% 59% XXX XXX
EBITDA $98.0M $104M $102M $124M XXX
EBITDA Margin 26% 28% 26% 29% XXX
Net Profit $196M $70.5M $68.1M XXX XXX
Net Margin 52% 19% 17% XXX XXX
Net Debt n/a n/a n/a XXX XXX

Financial data powered by Morningstar, Inc.

GSK India Stock Performance

As of February 10, 2025, GSK India's stock price is INR 2204 (or $25).

GSK India has current market cap of INR 373B (or $4.3B), and EV of INR 352B (or $4.1B).

See GSK India trading valuation data

GSK India Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$4.1B $4.3B XXX XXX XXX XXX $0.58

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

GSK India Valuation Multiples

As of February 10, 2025, GSK India has market cap of $4.3B and EV of $4.1B.

GSK India's trades at 9.6x LTM EV/Revenue multiple, and 32.8x LTM EBITDA.

Analysts estimate GSK India's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for GSK India and 10K+ public comps

GSK India Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $4.1B XXX XXX XXX
EV/Revenue 9.7x XXX XXX XXX
EV/EBITDA 33.6x XXX XXX XXX
P/E 47.6x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get GSK India Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

GSK India Valuation Multiples

GSK India's NTM/LTM revenue growth is 11%

GSK India's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $43K for the same period.

Over next 12 months, GSK India's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate GSK India's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for GSK India and other 10K+ public comps

GSK India Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 7% XXX XXX XXX XXX
EBITDA Margin 29% XXX XXX XXX XXX
EBITDA Growth -2% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 40% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $43K XXX XXX XXX XXX
S&M Expenses to Revenue 5% XXX XXX XXX XXX
G&A Expenses to Revenue 1% XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 34% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Medical Devices
Consumer SaaS
Streaming Platforms
AdTech Software
Climate Tech
GRC Software
Developer Tools

GSK India Public Comps

See valuation multiples for GSK India public comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

GSK India M&A and Investment Activity

GSK India acquired  XXX companies to date.

Last acquisition by GSK India was  XXXXXXXX, XXXXX XXXXX XXXXXX . GSK India acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by GSK India

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About GSK India

When was GSK India founded? GSK India was founded in 1924.
Where is GSK India headquartered? GSK India is headquartered in India.
How many employees does GSK India have? As of today, GSK India has 3.2K+ employees.
Is GSK India publicy listed? Yes, GSK India is a public company listed on BOM.
What is the stock symbol of GSK India? GSK India trades under 500660 ticker.
When did GSK India go public? GSK India went public in 1991.
Who are competitors of GSK India? Similar companies to GSK India include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics.
What is the current market cap of GSK India? GSK India's current market cap is $4.3B
What is the current revenue of GSK India? GSK India's last 12-month revenue is $421M.
What is the current EBITDA of GSK India? GSK India's last 12-month EBITDA is $124M.
What is the current EV/Revenue multiple of GSK India? Current revenue multiple of GSK India is 9.6x.
What is the current EV/EBITDA multiple of GSK India? Current EBITDA multiple of GSK India is 32.8x.
What is the current revenue growth of GSK India? GSK India revenue growth between 2023 and 2024 was 7%.
Is GSK India profitable? Yes, GSK India is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.